Earnings History Data for Charles River Laboratories International, Inc. (CRL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. At Charles River, they are passionate about their role in improving the quality of people's lives. Their mission, their excellent science and strong sense of purpose guide in all that they do, and they approach each day with the knowledge that their work helps to improve the health and well-being of many across the globe. Charles River Laboratories International, Inc. service areas are Basic research, discovery, safety and efficacy, clinical support and manufacturing.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-02-2024 PM CRL Charles River Laboratories International, Inc. 11,580 2.46 2.39 2.98 Charles River Laboratories Non-GAAP EPS of $2.46 beats by $0.06, revenue of $1.01B beats by $18.75M
[2/14/2024 7:17 AM]
245.21 24.97 
(11.34%)
228.10 7.86 
(3.57%)
161.65 - 257.17 1,452,722 500,000 16,276
08-11-2023 PM CRL Charles River Laboratories International, Inc. 9,300 2.72 2.35 2.63 Charles River Laboratories Non-GAAP EPS of $2.72 beats by $0.35, revenue of $1.03B beats by $30M
[11/8/2023 7:01 AM]
175.89 -6.92 
(-3.79%)
179.00 -3.81 
(-2.08%)
161.65 - 262.00 867,915 710,000 727
09-08-2023 PM CRL Charles River Laboratories International, Inc. 10,510 2.69 2.63 2.77 Charles River Laboratories beats Q2 top and bottom line estimates; raises FY23 outlook
[8/9/2023 7:07 AM]
215.33 9.09 
(4.41%)
212.00 5.76 
(2.79%)
181.22 - 262.00 817,829 460,000 11,838
11-05-2023 PM 7:00 AM ET
(May 11)
CRL Charles River Laboratories International, Inc. 9,600 2.78 2.59 2.75 Charles River Laboratories Non-GAAP EPS of $2.78 beats by $0.19, revenue of $1.03B beats by $43.94M
[5/11/2023 7:02 AM]
195.49 9.19 
(4.93%)
190.23 3.93 
(2.11%)
181.22 - 262.00 1,051,921 530,000 3,683
22-02-2023 PM 7:00 AM ET
(Feb 22)
CRL Charles River Laboratories International, Inc. 12,940 2.98 2.75 2.49 Charles River Laboratories beats Q4 top and bottom line estimates; initiates FY23 outlook
[2/22/2023 7:02 AM]
217.85 -25.75 
(-10.57%)
215.00 -28.60 
(-11.74%)
181.36 - 308.15 2,062,676 540,000 14,817
02-11-2022 PM 7:00 AM ET
(Nov 2)
CRL Charles River Laboratories International, Inc. 10,800 2.63 2.51 2.70 Charles River Laboratories Non-GAAP EPS of $2.63 beats by $0.13, revenue of $989.2M beats by $18.77M, updates FY guidance
[11/2/2022 7:10 AM]
216.35 9.06 
(4.37%)
211.00 3.71 
(1.79%)
181.36 - 441.91 1,063,582 640,000 154
03-08-2022 PM 7:00 AM ET
(Aug 3)
CRL Charles River Laboratories International, Inc. 12,040 2.77 2.74 2.61 222.01 -21.65 
(-8.89%)
243.66 0.0 
(0.00%)
203.37 - 460.21 1,626,374 470,000 3,767
04-05-2022 PM 7:00 AM ET
(May 4)
CRL Charles River Laboratories International 12,193 2.75 2.71 0.00 Charles River Laboratories Non-GAAP EPS of $2.75 beats by $0.03, revenue of $913.9M beats by $5.26M; updates FY22 guidance
[5/4/2022 7:05 AM]
258.39 7.20 
(2.87%)
251.19 0.0 
(0.00%)
230.62 - 460.21 895,200 780,000 2,599
16-02-2022 PM 7:00 AM ET
(Feb 16)
CRL Charles River Laboratories International, Inc. 16,520 2.49 2.42 2.39 Charles River Laboratories Non-GAAP EPS of $2.49 beats by $0.06, revenue of $905.05M beats by $16.78M
[2/16/2022 7:05 AM]
305.74 -6.89 
(-2.20%)
301.00 -11.63 
(-3.72%)
259.02 - 460.21 1,100,299 450,000 9,541
03-11-2021 PM 7:00 AM ET
(Nov 3)
CRL Charles River Laboratories International, Inc. 22,190 2.70 2.57 2.33 Charles River Laboratories EPS beats by $0.12, misses on revenue
[11/3/2021 7:09 AM]
387.93 -44.02 
(-10.19%)
400.00 -31.95 
(-7.40%)
224.06 - 460.21 1,589,047 270,000 816
04-08-2021 PM 7:00 AM ET
(Aug 4)
CRL Charles River Laboratories International, Inc. 20,380 2.61 2.39 1.58 Charles River Laboratories EPS beats by $0.23, beats on revenue
[8/4/2021 7:15 AM]
416.31 5.07 
(1.23%)
416.31 0.0 
(0.00%)
197.33 - 420.25 457,909 280,000 3,132
04-05-2021 PM 7:10 AM ET
(May 4)
CRL Charles River Laboratories International, Inc. 16,760 2.53 2.19 1.84 Charles River Laboratories EPS beats by $0.34, beats on revenue
[5/4/2021 7:16 AM]
338.96 7.01 
(2.11%)
338.96 0.0 
(0.00%)
136.00 - 343.47 650,978 300,000 1,786
17-02-2021 PM 7:00 AM ET
(Feb 17)
CRL Charles River Laboratories International, Inc. 14,560 2.39 2.12 2.01 Charles River Laboratories EPS beats by $0.28, beats on revenue
[2/17/2021 7:10 AM]
299.74 13.00 
(4.54%)
286.74 0.0 
(0.00%)
95.58 - 303.79 666,319 313,661 12,926
29-10-2020 PM 7:00 AM ET
(Oct 29)
CRL Charles River Laboratories International, Inc. 11,570 2.33 1.80 1.69 Charles River Laboratories EPS beats by $0.53, beats on revenue
[10/29/2020 7:09 AM]
228.94 6.94 
(3.13%)
222.00 0.0 
(0.00%)
95.58 - 250.29 574,556 347,313 88,649
05-08-2020 PM 7:00 AM ET
(Aug 5)
CRL Charles River Laboratories International, Inc. 9,850 1.58 1.27 1.63 Charles River Laboratories EPS beats by $0.30, beats on revenue
[8/5/2020 7:15 AM]
215.06 11.14 
(5.46%)
203.92 0.0 
(0.00%)
95.58 - 216.68 314,708 282,030 6,441